According to Mochida Pharmaceutical's latest financial reports the company's current EPS (TTM) is $1.84. a decrease over its 2023 EPS that were of $1.34.
Year | EPS | Change |
---|---|---|
2024 | $0.84 | -37.58% |
2023 | $1.34 | -41.1% |
2022 | $2.28 | 13.51% |
2021 | $2.01 | 83.55% |
2020 | $1.09 | -42.98% |
2019 | $1.92 | -10.29% |
2018 | $2.14 | 10.77% |
2017 | $1.93 | 5.77% |
2016 | $1.82 | 16.09% |
2015 | $1.57 | -33.61% |
2014 | $2.37 | 0.93% |
2013 | $2.35 | -9.69% |
2012 | $2.60 | 78.78% |
2011 | $1.45 | -37.21% |
2010 | $2.31 | 21.31% |
2009 | $1.91 | 11.77% |
2008 | $1.71 | 64.34% |
2007 | $1.04 | 23.52% |
2006 | $0.84 | 104.87% |
2005 | $0.41 |